Clinical Trials Browser

Phase 1/2 × Immune Checkpoint Inhibitors × Gastrointestinal × Clear all

Turcot syndrome, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07282184 2025-12-18

Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention

Phase 1/2 Recruiting

144 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT04954599 2025-10-07

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Phase 1/2 Recruiting

126 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

NCT05497453 2025-02-03

MYCHELANGELO I

Phase 1/2 Terminated

24 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05937438 2025-01-29

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

Phase 1/2 Recruiting

70 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT04721223 2024-09-19

JAB-3068 Activity in Adult Patients With Advanced Solid Tumors

Phase 1/2 Completed

12 enrolled

GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT05716295 2024-05-08

ORCHID-1

Phase 1/2 Terminated

26 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT06074029 2024-02-08

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

Phase 1/2 Unknown

50 enrolled

Gastrointestinal

Biliary Tract Neoplasms

NCT06022692 2023-09-05

HEAIS001

Phase 1/2 Completed

18 enrolled

Gastrointestinal

Hyperthermia, Digestive System Neoplasms

NCT05777707 2023-03-21

Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma

Phase 1/2 Unknown

89 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT04110093 2020-12-30

Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer

Phase 1/2 Unknown

120 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03989310 2020-12-23

An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer

Phase 1/2 Unknown

50 enrolled

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT04004234 2019-07-09

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Phase 1/2 Unknown

20 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Neoplasm Metastasis

NCT03311789 2017-10-17

Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCs

Phase 1/2 Unknown

30 enrolled

Gastrointestinal

Biliary Tract Neoplasms

Clinical Trials

SYLVER

Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

MYCHELANGELO I

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

JAB-3068 Activity in Adult Patients With Advanced Solid Tumors

ORCHID-1

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

HEAIS001

Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma

Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer

An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCs